Recruiting

Endoscopic Intestinal Re-Cellularization

Sponsor:

Endogenex, Inc.

Code:

NCT06267391

Conditions

Type 2 Diabetes Mellitus

Type2diabetes

Diabetes Mellitus, Type 2

Diabetes

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 22 - 70

Healthy Volunteers: Not accepted

Interventions

ReCET Treatment

Sham Procedure

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-17. This information was provided to ClinicalTrials.gov by Endogenex, Inc. on 2025-03-05.